Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Island Pharmaceuticals (ILA AU)
Watchlist
13
Analysis
Health Care
•
Australia
Island Pharmaceuticals Limited operates as a drug research and repurposing company. The Company focuses on developing preventative or therapeutic drugs for viral infections. Island Pharmaceuticals serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Island Pharmaceuticals
•
06 Oct 2026 06:00
•
Issuer-paid
Island Pharmaceuticals Ltd - Galidesivir manufacturing commenced for Ebola deployment
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. ILA has announced that GMP manufacture of...
Research as a Service (RaaS)
Follow
88 Views
Share
bullish
•
Island Pharmaceuticals
•
24 Aug 2026 08:00
•
Issuer-paid
Island Pharmaceuticals Ltd - Second manufacturing campaign of Galidesivir for outbreak
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. ILA has commissioned a second...
Research as a Service (RaaS)
Follow
98 Views
Share
bullish
•
Island Pharmaceuticals
•
05 Aug 2026 14:13
Primer: Island Pharmaceuticals (ILA AU) - Aug 2026
Island Pharmaceuticals is a clinical-stage biotechnology company focused on a drug repurposing strategy to develop antiviral therapeutics for...
αSK Primers
92 Views
Share
bullish
•
Island Pharmaceuticals
•
03 Aug 2026 06:00
•
Issuer-paid
Island Pharmaceuticals Ltd - Bundibugyo Ebola outbreak accelerates
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. As detailed in our previous note, the...
Research as a Service (RaaS)
Follow
114 Views
Share
bullish
•
Island Pharmaceuticals
•
08 Jul 2026 15:00
•
Issuer-paid
Island Pharmaceuticals Ltd - Galidesivier approved for use in Ebola epidemic
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. The company has announced that, in...
Research as a Service (RaaS)
Follow
117 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x